Bulkamid
Commercial- Indications
- Stress urinary incontinence
Company intelligence / Profile preview
Speciality European Pharma
London, United Kingdomcontura.com ↗
- Ownership
- Private
- Employees
- ~13
- Development stage
- Commercial
01
Overview
Speciality European Pharma was a specialty pharmaceutical company focused on acquiring and commercializing urology and urogynaecology products for the European market. Its portfolio included marketed brands such as Regurin® for overactive bladder and Mitem®/Mitocin for non-muscle invasive bladder cancer. The company also distributed device-based therapies like Bulkamid® for urinary incontinence. SEP operated its own sales force across Europe before being acquired by Juno/Aspire Pharmaceuticals in 2016[3][5].
- Therapeutic areas
- Women's HealthOncologyUrologyNephrology
- Modalities
- Small moleculeDevice
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Licensing deals with Curasan AGexclusive UK distribution rights agreementsproduct licensing/acquisition partnerships within the EU urology market
Beyond the preview
Go deeper on Speciality European Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Speciality European Pharma.